| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |